Encompass Health director Herman receives 81 stock units

The award reflected dividend-linked RSUs credited under the director's outstanding restricted stock unit agreements.

Rhea-AI Filing Summary

Encompass Health Corp (EHC) director Joan E. Herman acquired 81 restricted stock units on October 15, 2026, under outstanding award agreements that credit additional RSUs in connection with common stock dividends. Encompass Health paid a $0.21 per-share dividend that day, when the closing price was $127.77. Her reported direct holdings following the award were 49,724 shares.

Insider Trade Summary

Grant/Award: 81 shares

Grant/Award 1 txn

Insider HERMAN JOAN E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock F1	81	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 49,724 shares (Direct)

Footnotes (1)

1. F1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2026, Encompass Health paid a dividend on its common stock of $0.21 per share and the closing price was $127.77. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

Key Figures

RSUs awarded: 81 shares Dividend: $0.21 per share Closing price: $127.77 +1 more

4 metrics

RSUs awarded 81 shares October 15, 2026

Dividend $0.21 per share Paid October 15, 2026

Closing price $127.77 October 15, 2026

Direct holdings following award 49,724 shares Following the October 15, 2026 transaction

Key Terms

restricted stock unit award agreements, dividend record date, dividend payment date

3 terms

restricted stock unit award agreements financial

"Pursuant to outstanding restricted stock unit award agreements"

dividend record date financial

"in each director's account on the associated dividend record date"

dividend payment date financial

"the closing price on the dividend payment date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RSUs did EHC director Joan E. Herman receive?

Joan E. Herman, a director of Encompass Health, received an award of 81 restricted stock units on October 15, 2026. The award was associated with the dividend payment.

How were Joan E. Herman's Encompass Health dividend-related RSUs calculated?

The RSUs credited were calculated by multiplying the RSUs in each director's account on the associated dividend record date by the per-share dividend, then dividing by the closing price on the dividend payment date. Encompass Health paid a $0.21 per-share dividend on October 15, 2026, and the closing price that day was $127.77.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/19/2026 - 03:42 PM EDT Accepted by SEC EDGAR 10/19/2026 - 03:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HERMAN JOAN E

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	10/15/2026		A		81(1)	A	$0	49,724	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2026, Encompass Health paid a dividend on its common stock of $0.21 per share and the closing price was $127.77. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

Remarks:

	/s/ Patrick Darby, attorney-in-fact for Joan E. Herman	10/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)